Geron | GERN - Cash And Equivalent

Stock Price
1.49
Daily Change
0.02 1.36%
Monthly
12.88%
Yearly
-50.66%
Q1 Forecast
1.33

Geron reported $79.99M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Amgen USD 9.13B 316M Dec/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Cassava Sciences USD 106.08M 6.3M Sep/2025
Cytokinetics USD 225.47M 150.53M Sep/2025
Exelixis USD 376.3M 211.87M Sep/2025
Genmab DKK 1.3B 323M Jun/2025
Geron USD 79.99M 389K Sep/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
Incyte USD 2.93B 508.08M Sep/2025
MacroGenics USD 80.13M 50.56M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025